( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57



Dr. Lisa Jennifer Dsouza, *Dr. Govardhan J., Dr. Umadevi K. P., Dr. Ilakkia P. Sadasivam, Dr. Rajkiran Takharya


Introduction: COVID-19came as a grave pandemic in December 2019, shaking the entire world and leading to tremendous morbidity and mortality. Though the primary symptoms were respiratory leading to pneumonia but increased dermatological manifestations were also seen in many COVID positive patients. These were reported in the form of various types ofexanthems and enanthems. Though there is limited data regarding the pathogenesis for these and exact correlation is yet to be proved, we have conducted a study to evaluate the dermatological manifestations related to COVID-19 at a tertiary care hospital in Puducherry. Aim and Objectives: To find the most common dermatological presentations in COVID -19 patients. To assess the temporal relationship of dermatological and systemic manifestations of COVID-19 and to compare the correlation between the severity of systemic complaints and dermatological manifestation in COVID 19 patients. Materials and Methods: A cross sectional study was performed in the dermatology OPD, a total of 300 participants were included over a period of six months. The study included all consecutiveconsenting patients aged 7 to 90 years with RT-PCR positive who were previously diagnosed COVID-19 attending dermatology OPD and of both sexes. Pregnant women were excluded from the study. Results: Out of 300 participants, male preponderance was seen (65%). 41 patients (13.6%)were admitted in the ICU. Comorbidities like diabetes mellitus were seen in 71 patients (23.6%) and 22 (7%) had hypertension. The CT severity score was mild moderate and severe in respect of 3.6%, 11.6% and 5%.Urtricarial rash was seen in 3 patients, maculopapular rash in 9 and chillbains in 2 patients. Mucosal involvement was seen in 14 (4.6%) patients. 197(65.6%)showed COVID associated hairfall. Conclusion: Cutaneous manifestation may be the primary sign of patients suffering from Covid 19 and could have an association with the severity of the disease and therefore should not be missed.

Keywords: COVID-19, Exanthem, morbilliform, chill-blain.

[Full Text Article] [Download Certificate]


  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44



  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 March 2024 Issue has been Published, Kindly check it on


    MARCH 2024 issue has been successfully launched on MARCH 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia